ArrowMark Partners
Funding rounds backed by ArrowMark Partners.
- Funding disclosed in full
- $345M
- Median round
- $172.5M
- Rounds in calculation
- 2
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Poplar Therapeutics Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions | $45MSeries A+ | BiotechUnited States | |||
| Skyryse Develops automated flight control systems for aircraft | $300MSeries C | MobilityUnited States |